Todd Krueger
Chief Executive Officer AOBiome
Todd Krueger is Chief Executive Officer, President, and Director of Prenetics, where he leads corporate strategy, business development, and overall operations. With more than 20 years of experience in healthcare strategy, finance, and commercialization, he has held leadership roles across biotechnology and life sciences organizations, including Fluidigm Corporation, Life Technologies Corporation, Broad Institute, and Claritas Genomics. A graduate of Northwestern University and its Kellogg School of Management, he also serves on the boards of several innovative biotechnology companies focused on drug delivery, lipid nanoparticle technologies, and microbiome research.
Seminars
Wednesday 11th November 2026
Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies
9:00 am
- Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
- Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
- Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand
